BRIEF-Cel-Sci receives partial clinical hold letter from FDA

* Cel-Sci provides update on partial clinical hold on phase 3 clinical trial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.